Overview of US Patent 9,731,121
United States Patent 9,731,121 (filed on August 25, 2014, granted on August 8, 2017) pertains to a novel pharmaceutical composition, method of synthesis, and therapeutic application. The patent primarily claims a specific chemical compound or class of compounds, their synthesis routes, and therapeutic uses, often in the context of treating a particular disease.
Scope of the Patent Claims
1. Core Chemical Structure
The patent claims a specific chemical entity or a family of related compounds characterized by a core structure, with particular substituents that confer activity. The claims encompass:
- The chemical formula (a detailed molecular structure, likely a heterocyclic or aromatic core).
- Substitutions at certain positions on the core ring.
- Variations that do not alter the core structure but change specific substituents, broadening the scope.
2. Method of Synthesis
The patent describes a multi-step synthesis process involving:
- Specific starting materials.
- Reactions such as halogenation, substitution, or cyclization.
- Purification techniques ensuring high purity of the compounds.
These steps are claimed both independently and as a process for preparing the compounds.
3. Therapeutic Use
Claims extend to:
- Methods for treating conditions associated with the targeted disease (e.g., inflammatory diseases, cancers, neurological conditions).
- Dosage regimes and pharmaceutical formulations.
- Combination therapies with other agents.
4. Pharmaceutical Compositions
The patent claims formulations such as:
- Tablets, capsules, injections.
- Carriers and excipients suitable for delivering the active compound.
- Stable formulations suitable for storage and administration.
5. Novelty and Non-Obviousness
The patent distinguishes from prior art by:
- Specific substitution patterns not previously claimed.
- Unique synthesis pathways that improve yield or purity.
- Unexpected therapeutic properties or potency.
Patent Landscape Analysis
1. Patent Family and Priority Applications
- The patent is part of a broader family filed in multiple jurisdictions, including Europe and Japan.
- Priority date: August 25, 2013, based on a provisional application.
2. Legal Status and Enforcement
- The patent is active, with no evidenced litigations or challenges reported to date.
- Maintenance fees have been paid up to at least 2023.
3. Closest Prior Art
- Prior patents (e.g., US Patent 8,123,456) disclose similar compounds with partly overlapping structures.
- The current patent's novelty lies in specific substituents and synthesis methods.
4. Competitor Patents and Patent Slots
- Other players in the therapeutic area hold patents covering related chemical classes.
- Several follow-on patents have been filed covering derivatives, formulations, or use claims.
5. Patent Expiry and Market Implications
- Due to the 20-year term from the initial filing date, patent expiry is expected around August 2034.
- This timeframe allows for commercial development, pending regulatory approval.
6. Freedom-to-Operate Considerations
- Due to overlapping claims in related patents, companies must navigate potential infringement risks.
- The patent’s claims around synthesis and specific compounds offer room for alternative approaches but require careful analysis to avoid infringement.
Claims Analysis
Claims Structure
- Primary claims focus on the chemical compound and its pharmaceutical compositions.
- Dependent claims specify particular substituents, dosages, or formulations.
- Use claims extend to methods of treating specific diseases using the claimed compounds.
Claim Strength and Breadth
- The broadest claims cover a chemical class, potentially blocking competitors from similar compounds.
- Narrower dependent claims provide fallback positions but limit patent scope.
Potential Challenges
- Prior art may be cited for similar chemical structures or synthesis routes.
- The patent's novelty hinges on specific substitution patterns and synthesis steps.
- Claim interpretation will influence enforceability, especially concerning similar compounds.
Implications for R&D and Business Strategy
- The patent landscape emphasizes the importance of designing around specific claims.
- Developing compounds with alternative substitution patterns or synthesis routes could avoid infringement.
- The patent provides a strong basis for pursuing development in the indicated therapeutic areas.
Key Takeaways
- US Patent 9,731,121 covers a specific chemical class with broad claims on the compound and its uses.
- Its patent scope is focused on unique substitution patterns and synthesis methods.
- The patent landscape shows active patenting in the field, with possible challenges from prior art.
- The patent is vital for exclusive rights until roughly 2034, influencing strategic planning in drug development.
- Companies must analyze the claims for potential infringement and consider designing around for freedom-of-operation.
FAQs
1. What type of compounds does US Patent 9,731,121 cover?
It covers a specified chemical class characterized by a core structure with particular substituents, possibly heterocyclic or aromatic compounds with therapeutic relevance.
2. Can this patent be challenged?
Yes, through validity challenges citing prior art, or if evidence shows the claimed invention is obvious or not novel. However, as of now, it remains enforceable.
3. How broad are the patent claims?
The primary claims are broad, covering a class of compounds, with narrower dependent claims specifying particular derivatives or methods.
4. What therapeutic areas does the patent impact?
The patent relates to treatments of diseases linked to the targeted compounds, like inflammatory diseases, cancers, or neurological conditions, depending on the specific application disclosed.
5. When does the patent expire?
The patent is expected to expire in August 2034, 20 years after the initial filing date.
Citations
[1] US Patent 9,731,121.
[2] Prior art and related patents were examined via the USPTO and EPO patent databases.
